|
HS Code |
574318 |
| Product Name | 3-Bromo-5-Chloromethylpyridine Hydrochloride |
| Cas Number | 1349714-25-3 |
| Molecular Formula | C6H5BrClN2·HCl |
| Molecular Weight | 259.45 g/mol |
| Synonyms | 5-(Chloromethyl)-3-bromopyridine hydrochloride |
| Appearance | White to off-white solid |
| Solubility | Soluble in water and most organic solvents |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
As an accredited 3-Bromo-5-Chloromethylpyridine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-5-Chloromethylpyridine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every now and then, a compound quietly changes the rhythm of research in pharmaceuticals and specialty chemicals. 3-Bromo-5-Chloromethylpyridine Hydrochloride falls into that group. As someone who has watched the continual push for more precise and more reliable starting materials, I find this compound’s role both fascinating and under-appreciated. In the world of modern chemistry, it’s not just about following recipes — it’s about shaping what research can achieve from the very beginning. Its structure, marked by the combination of bromine at the 3-position and a chloromethyl group at the 5-position on a pyridine ring, sets it apart from other pyridines, pushing synthetic boundaries and enabling access to unique molecular scaffolds.
The chemical world thrives on small differences that become major advantages. The fine details — such as the exact arrangement of halogens on a pyridine ring like in 3-Bromo-5-Chloromethylpyridine Hydrochloride — matter more than most non-chemists might guess. In this case, the model typically supplied to laboratories comes as a white to off-white crystalline hydrochloride salt. Clear melting range and a stable shelf life under cool, dry storage allow chemists to forecast their experiments with confidence. The crystalline nature makes for straightforward handling, as powders can be difficult and unpredictable in humidity. From experience, even slight changes in moisture during synthesis can disrupt an entire series of experiments, leading to waste and lost time. Having a compound that remains stable and consistent day after day makes for less late-night anxiety in the lab. Standard packaging includes tight-sealing bottles to keep the hydrochloride salt uncompromised during transit or storage.
Complex drug pipelines depend on reliable feedstocks, and 3-Bromo-5-Chloromethylpyridine Hydrochloride checks crucial boxes. Its combination of functional groups opens up synthetic strategies that just aren’t possible with unsubstituted or mono-halogenated pyridines. The bromine at the third position sets the scene for cross-coupling reactions, including Suzuki or Buchwald-Hartwig types, where the bromine’s reactivity allows attachment of sophisticated functional fragments. At the same time, the chloromethyl handle at the fifth position invites nucleophilic substitution, giving medicinal chemists a two-pronged route to diversify their compound libraries. While similar molecules might require labor-intensive protection and deprotection steps or bring reactivity that's hard to control, this compound delivers a streamlined path to new structures. In conversations with medicinal chemistry teams, I’ve heard repeated appreciation for materials that respond predictably, cutting down on “troubleshooting” cycles that can eat up both budgets and timelines.
This compound’s main supporters usually come from the pharmaceutical and agrochemical sectors. It serves as a backbone for the creation of kinase inhibitors, anti-infective agents, and herbicides, just to name a few applications. In recent years, with the push for precise, targeted therapies, companies have geared up to build libraries of substituted pyridines for screening against a wider range of biological targets. In these projects, each extra step or isolated yield loss can cascade into a massive increase in cost and a slowdown that amplifies at scale. Given its versatile substitution pattern and ease of transformation, 3-Bromo-5-Chloromethylpyridine Hydrochloride gives researchers flexibility to respond to new data as compounds move down the development funnel. For smaller synthesis runs, it works as an anchor in fragment-based drug discovery, where chemistries must remain clean and scalable. One medicinal chemist described it to me as their “Swiss army knife” when exploring new leads in pyridine series, comparing its flexibility to more rigid building blocks that can only do one job well.
Cost and availability tend to dictate the fine balance in compound selection, but quality often tips the scale for synthesis-driven organizations. Creating unique molecular architectures sometimes calls for more than just standard 3-bromopyridine or 5-chloromethylpyridine hydrochloride. The dual functionalization on this molecule spares chemists extra synthetic work — no need to install a reactive group, then run protection steps, then deprotect and purify. Too often, I’ve seen teams bogged down by side-reactions or dealing with impurities from laborious multi-step modifications. By picking 3-Bromo-5-Chloromethylpyridine Hydrochloride, they can leapfrog over these bottlenecks and focus efforts where innovative thinking actually moves the project forward, rather than “rescuing” impure starting stocks or correcting selectivity problems.
While it isn’t the cheapest reagent, many find the investment pays off in reliability. Analytical purity from reputable suppliers usually exceeds 98%, and the consistency in halide ratio eases batch-to-batch variation headaches. In many regulatory submissions, documented consistency in starting materials now counts as a major mark for quality and for process safety. Colleagues in process chemistry circles often stress how crucial it is to cut out variability early on. Anything less predictable can lead to downstream issues in both risk assessment and regulatory review. It all starts with molecules like this one, built not just for chemical reactivity, but for real-world project timelines and compliance.
Handling halomethylated pyridines comes with its set of safety and environmental liabilities. In scaling up from milligram-scale synthesis to pilot or kilo-lab operations, teams must enforce protection against volatile halides and dust inhalation. I’ve seen mistakes made from simple lapses like using an open beaker or skipping personal protective equipment. To address these, many organizations look to better ventilation solutions, closed-system transfers, and strict training regimens for lab staff. Sodium thiosulfate or sodium bisulfite can neutralize halogenated waste streams safely, provided protocols match national regulations. Scientists working with these sorts of molecules appreciate suppliers who can provide certificates of analysis, detailed impurity profiles, and guidance on occupational exposure standards to keep everyone on the right side of compliance.
Disposal creates its own hurdles. As governments continue to tighten rules around halogenated organic waste, it pays to keep process footprints as lean as possible. Teams adopting green chemistry principles are re-examining their workflows to reduce the use of excess halide, optimize yields, and regenerate or recycle starting materials whenever feasible. Industry groups have started to recommend closed-loop solvent recycling and centralized collection for halogenated waste, pushing higher safety standards across the sector. Reducing environmental impact, though, doesn't need to trade off with innovation — strong project planning ensures both product excellence and sustainable operations.
One way to appreciate the significance of 3-Bromo-5-Chloromethylpyridine Hydrochloride comes from seeing how research has changed over just the past decade. At a time when more pharmaceutical innovations come from “small pockets” rather than big institutions, having access to better reagents lowers the barriers for independent synthesis teams. Specialty chemical companies, CROs, and university labs alike can take a concept from paper to proof-of-principle without waiting on custom syntheses or long overseas lead times. Faster access to key building blocks means timelines shrink from years to months, even weeks — and that speed can make all the difference in disease-focused research where urgency saves lives.
Broad adoption of modular building blocks like this one has recalibrated what’s considered “state of the art” in medicinal chemistry. Libraries of analogs around the pyridine core provide essential structure-activity relationship (SAR) data, while allowing for tailored property modification like solubility improvement or metabolic tuning. A recent trend has seen more “growable” molecular centers like this, where a single molecule holds the seeds of many final drug candidates or chemical probes, each a quick transformation away.
Whereas classic syntheses might have required six or more steps just to create an interesting intermediate, 3-Bromo-5-Chloromethylpyridine Hydrochloride opens the door to two-step divergences — bromine coupling one way, chloromethyl substitution another. For a start-up, academic, or big pharma lab, these are not small time savings; they fundamentally shift how quickly new compounds appear in screening sets, accelerate answers to core research questions, and raise the bar for what is possible within a grant cycle or early-stage investment period.
Any chemist can tell you sourcing choices make or break an experiment. Choosing 3-Bromo-5-Chloromethylpyridine Hydrochloride isn’t just about price; it’s about trust in product consistency, responsiveness from suppliers, and clear documentation for every batch. Some procurement officers focus heavily on batch sizes or lowest upfront costs, but the more seasoned professionals look for thorough auditable records, thorough impurity testing, and real customer support. For regulated environments, I’ve seen projects derailed over subtle issues like unclear certification of starting materials, with entire batches rerun at major expense.
Reputable suppliers will go the distance in offering full analytical panels, details on synthetic route, and have technical staff to advise on specific batch compatibilities. In urgent projects, rapid response times—a call-back or emailed COA within hours rather than days—mean teams spend less time in bureaucratic limbo and more in research. Those extra layers of trust don’t come from abstract compliance slogans, but from direct feedback, transparency, and a readiness to troubleshoot together if anything arises with the batch supplied.
Having followed the evolution of halopyridine chemistry in professional and academic circles, the best advances tend to come when the right reagents are paired with teams confident in their properties. Too often, a poor choice at the input stage means troubleshooting mystery artifacts, hunting for side-products, or scaling up only to hit dead ends. Over time, the best practitioners learn to lean on reagents like 3-Bromo-5-Chloromethylpyridine Hydrochloride for its balance of reactivity, manageability, and purity. These features aren’t marketing fluff—they translate to fewer failures, more robust data, and reproducibility across sites or researchers. With pharmaceutical projects pushing for higher speed and quality at lower cost, strong inputs make a material difference.
Some may argue that one can always “work around” less ideal inputs, and any new chemistry comes at the cost of trickier purification, more waste, or unpredictable problems in scale-up. From my vantage point, the smarter move is to support projects by investing in advanced intermediates like this, avoiding “reinventing the wheel” at each synthesis or resorting to labor-intensive workaround methods. Choosing a compound crafted with process chemistry in mind means fewer dropped projects, less risk of hidden impurities, and a safer overall laboratory environment.
With stricter global regulations, more complex drug pipelines, and rising cost pressures across R&D, chemical building blocks that can deliver on both safety and reactivity will only grow in importance. Reliable 3-Bromo-5-Chloromethylpyridine Hydrochloride isn’t just an ingredient in a protocol — it embodies a whole set of values: transparency, predictability, and collaboration between suppliers and users. As green chemistry principles take stronger hold, the focus on sustainable sourcing, batch accountability, and reduced waste through fewer purification steps puts specialty reagents like this one in the spotlight.
Given ongoing trends toward personalized medicine, orphan drugs, and specialty crop protection products, demand for versatile intermediates is only likely to increase. From my perspective, well-selected reagents enable smaller research teams (including those with modest resources) to stay competitive, moving new ideas from the bench to reality faster and with fewer resource bottlenecks. It’s a shift that not only levels the playing field but sets new expectations for supplier support, customer education, and downstream responsibility.
Reflecting on feedback from both industrial and academic chemists, there’s real gratitude for materials that don’t bring surprises. 3-Bromo-5-Chloromethylpyridine Hydrochloride, with its thoughtfully designed substitution pattern and stable hydrochloride salt, marks a new standard for efficiency in contemporary synthesis. For early-career chemists, it means simpler planning; for those heading up commercial projects, it cuts weeks off timelines and trims costs where it counts. The downstream benefits are clear in cleaner data, faster project turnaround, and increased confidence when scaling up.
As chemistry looks for more sustainable, efficient, and reliable building blocks, products like this one lead by example. The compound’s integrity under real-world conditions—whether in small-scale exploratory synthesis or in pilot plant settings—reflects what forward-thinking labs demand from their tools. By closing the loop between supplier commitment and research needs, the sector is poised to benefit from cleaner, safer, and more pioneering science, all starting with rigorously crafted reagents that rise to the moment.